PURPOSE: Active smoking and passive smoking have been associated with increased risk of breast cancer. The purpose of the present study was to prospectively assess associations of smoking with breast cancer and identify subgroups at higher risk among African-American women. METHODS: Based on 1,377 incident cases identified during 14 years of follow-up in the Black Women's Health Study, we assessed active and passive smoking in relation to breast cancer incidence by menopausal status, estrogen receptor status, and other factors. Incidence rate ratios (IRR) and 95 % confidence intervals (CI) for categories of smoking relative to no active or passive smoking were calculated from Cox proportional hazards models, controlling for breast cancer risk factors. RESULTS: Active smoking was associated with increased risk of premenopausal breast cancer. The IRR was 1.21 (95 % CI 0.90-1.62) for premenopausal breast cancer overall and 1.70 (95 % CI 1.05-2.75) for premenopausal breast cancer associated with beginning smoking before age 18 together with accumulation of ≥20 pack years. The positive association with premenopausal breast cancer was most apparent for estrogen-receptor-positive cancer. Passive smoking was also associated with increased risk of premenopausal breast cancer (IRR = 1.42, 95 % CI 1.09-1.85), based on information on passive smoking at home and work. Neither active nor passive smoking was associated with increased risk of postmenopausal breast cancer. CONCLUSION: These results strengthen the evidence that both active and passive smoking increase the incidence of premenopausal breast cancer.
PURPOSE: Active smoking and passive smoking have been associated with increased risk of breast cancer. The purpose of the present study was to prospectively assess associations of smoking with breast cancer and identify subgroups at higher risk among African-American women. METHODS: Based on 1,377 incident cases identified during 14 years of follow-up in the Black Women's Health Study, we assessed active and passive smoking in relation to breast cancer incidence by menopausal status, estrogen receptor status, and other factors. Incidence rate ratios (IRR) and 95 % confidence intervals (CI) for categories of smoking relative to no active or passive smoking were calculated from Cox proportional hazards models, controlling for breast cancer risk factors. RESULTS: Active smoking was associated with increased risk of premenopausal breast cancer. The IRR was 1.21 (95 % CI 0.90-1.62) for premenopausal breast cancer overall and 1.70 (95 % CI 1.05-2.75) for premenopausal breast cancer associated with beginning smoking before age 18 together with accumulation of ≥20 pack years. The positive association with premenopausal breast cancer was most apparent for estrogen-receptor-positive cancer. Passive smoking was also associated with increased risk of premenopausal breast cancer (IRR = 1.42, 95 % CI 1.09-1.85), based on information on passive smoking at home and work. Neither active nor passive smoking was associated with increased risk of postmenopausal breast cancer. CONCLUSION: These results strengthen the evidence that both active and passive smoking increase the incidence of premenopausal breast cancer.
Authors: Michelle D Althuis; Jennifer H Fergenbaum; Montserrat Garcia-Closas; Louise A Brinton; M Patricia Madigan; Mark E Sherman Journal: Cancer Epidemiol Biomarkers Prev Date: 2004-10 Impact factor: 4.254
Authors: Changzhong Chen; Xiaobin Wang; Lihua Wang; Fan Yang; Genfu Tang; Houxun Xing; Louise Ryan; Bill Lasley; James W Overstreet; Joseph B Stanford; Xiping Xu Journal: Environ Health Perspect Date: 2005-04 Impact factor: 9.031
Authors: Avonne E Connor; Kathy B Baumgartner; Richard N Baumgartner; Christina M Pinkston; Stephanie D Boone; Esther M John; Gabriela Torres-Mejía; Lisa M Hines; Anna R Giuliano; Roger K Wolff; Martha L Slattery Journal: J Womens Health (Larchmt) Date: 2015-12-18 Impact factor: 2.681
Authors: Kathleen Conway; Sharon N Edmiston; Eloise Parrish; Christopher Bryant; Chiu-Kit Tse; Theresa Swift-Scanlan; Lauren E McCullough; Pei Fen Kuan Journal: Breast Cancer Res Treat Date: 2017-03-08 Impact factor: 4.872
Authors: Song-Yi Park; Julie R Palmer; Lynn Rosenberg; Christopher A Haiman; Elisa V Bandera; Traci N Bethea; Melissa A Troester; Emma Viscidi; Laurence N Kolonel; Andrew F Olshan; Christine B Ambrosone Journal: Carcinogenesis Date: 2016-04-07 Impact factor: 4.944
Authors: Eboneé N Butler; Chiu-Kit Tse; Mary Elizabeth Bell; Kathleen Conway; Andrew F Olshan; Melissa A Troester Journal: Cancer Causes Control Date: 2016-05-06 Impact factor: 2.506
Authors: Alexandra J White; Aimee A D'Aloisio; Hazel B Nichols; Lisa A DeRoo; Dale P Sandler Journal: Cancer Causes Control Date: 2017-05-18 Impact factor: 2.506
Authors: Mia M Gaudet; Brian D Carter; Louise A Brinton; Roni T Falk; Inger T Gram; Juhua Luo; Roger L Milne; Sarah J Nyante; Elisabete Weiderpass; Laura E Beane Freeman; Dale P Sandler; Kim Robien; Kristin E Anderson; Graham G Giles; Wendy Y Chen; Diane Feskanich; Tonje Braaten; Claudine Isaacs; Lesley M Butler; Woon-Puay Koh; Alicja Wolk; Hans-Olov Adami; Emily White; Karen L Margolis; Michael J Thun; Susan M Gapstur Journal: Int J Epidemiol Date: 2017-06-01 Impact factor: 7.196
Authors: Ugonna Ihenacho; Ann S Hamilton; Wendy J Mack; Anna H Wu; Jennifer B Unger; Dorothy R Pathak; Kelly A Hirko; Richard T Houang; Michael F Press; Kendra L Schwartz; Lydia R Marcus; Ellen M Velie Journal: Breast Cancer Res Treat Date: 2022-08-04 Impact factor: 4.624
Authors: Inger T Gram; Song-Yi Park; Gertraud Maskarinec; Lynne R Wilkens; Christopher A Haiman; Loïc Le Marchand Journal: Int J Epidemiol Date: 2019-04-01 Impact factor: 7.196
Authors: Inger T Gram; Song-Yi Park; Laurence N Kolonel; Gertraud Maskarinec; Lynne R Wilkens; Brian E Henderson; Loïc Le Marchand Journal: Am J Epidemiol Date: 2015-10-22 Impact factor: 4.897